Journal article · Clinical audiology← The news desk

✦ The Dispatch

Perilymphatic enhancement suggestive of blood-labyrinthine barrier dysfunction in tumor-negative unilateral asymmetric sensorineural hearing loss on 10-minute postcontrast 3D heavily T2-weighted FLAIR MRI

A dispatch from PubMed — filed

We hypothesized that a subset of patients with tumor-negative, nonacute unilateral asymmetric sensorineural hearing loss (ASNHL) would show occult perilymphatic enhancement suggestive of blood-labyrinthine barrier (BLB) dysfunction on 10-min postcontrast three-dimensional (3D) heavily T2-weighted fluid-attenuated inversion recovery (hvT2-FLAIR) magnetic resonance imaging (MRI)....

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No immediate change to routine audiology practice is warranted; this study adds to the diagnostic imaging evidence base and is more relevant to neuroradiology and ENT than to frontline hearing care.

✦ Why It Matters ✦

Demonstrating blood-labyrinthine barrier dysfunction via accessible MRI protocols may offer a non-invasive diagnostic tool for otherwise unexplained asymmetric hearing loss, reducing the diagnostic uncertainty that burdens both clinicians and patients.

✦ Key Points ✦
  1. 01Used 10-minute postcontrast 3D heavily T2-weighted FLAIR MRI to detect inner ear barrier dysfunction.
  2. 02Focused on tumor-negative patients with unilateral asymmetric sensorineural hearing loss.
  3. 03Perilymphatic enhancement was the imaging biomarker studied.
  4. 04Blood-labyrinthine barrier (the protective layer between blood vessels and inner ear fluid) dysfunction may explain some cases of asymmetric hearing loss.
  5. 05Published in a peer-reviewed ENT/otolaryngology journal.
✦ Claims & Evidence ✦

Perilymphatic enhancement on 10-minute postcontrast 3D T2-FLAIR MRI is a marker of blood-labyrinthine barrier dysfunction in tumor-negative asymmetric SNHL.

studypartially supported
✦ Research metadata ✦
PMID
43026355
DOI
10.1007/s00405-026-10806-8.
Journal
European Archives of Oto-Rhino-Laryngology
Publication type
research_article
Evidence level
4
Population
Tumor-negative patients with unilateral asymmetric sensorineural hearing loss
Intervention
10-minute postcontrast 3D heavily T2-weighted FLAIR MRI

Primary outcomes

Presence of perilymphatic enhancement as a marker of blood-labyrinthine barrier dysfunction

✦ Related stories ✦